Lilly(Eli) Return on Equity

Lilly(Eli) (LLY) currently reports a ROE of 78.84%. That is above the Healthcare sector average of -100.59%. Use the charts on this page to explore Lilly(Eli)'s ROE history and peer comparisons.

Lilly(Eli)'s ROE of 78.84% is higher than the Healthcare sector average of -100.59%. That is roughly 178.4% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Lilly(Eli)'s current 78.84% should be judged against Healthcare norms (sector average: -100.59%) and against LLY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of 78.84%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is -100.59%. From there, open related valuation or income-statement pages for Lilly(Eli), and consider following LLY for alerts when major investors trade the stock.

Lilly(Eli) is classified in the Healthcare sector. On ROE, it currently shows 78.84% versus a sector average near -100.59%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LLY with unrelated industries.